Dysregulation of the IFN system has long been recognized as a feature of many autoimmune rheumatic diseases, most notably systemic lupus erythematosus (SLE), Sjögren’s syndrome (pSS), dermatomyositis (DM), and systemic sclerosis (SSc) (10–12). Here, IFNA1 is linked to systemic lupus erythematosus.